Skip to main content

Table 7 Apolipoprotein E gene polymorphism genotype and allele frequencies in T2DM patients and controls

From: Association of CETP TaqI and APOE polymorphisms with type II diabetes mellitus in North Indians: a case control study

 

Total#

Male#

Female#

 

Patient n (%)

Control n (%)

Patient n (%)

Control n (%)

Patient n (%)

Control n (%)

E2E2*

1 (0.7)

0 (0)

1 (1.3)

0 (0)

0 (0)

0 (0)

E3E3*

101 (74.3)

197 (74.6)

55 (69.6)

88 (75.9)

46 (80.7)

109 (73.6)

E4E4*

1 (0.7)

1 (0.4)

1 (1.3)

0 (0)

0 (0)

1 (0.7)

E2E3*

11 (8.1)

19 (7.2)

8 (10.1)

9 (7.8)

3 (5.3)

10 (6.8)

E2E4*

4 (2.9)

6 (2.3)

2 (2.5)

5 (4.3)

2 (3.5)

1 (0.7)

E3E4*

18 (13.2)

41 (15.5)

12 (15.2)

14 (12.1)

6 (10.5)

27 (18.2)

E2*

17 (6.3)

25 (4.7)

12 (7.59)

14 (6.03)

5 (4.39)

11 (3.72)

E3*

231 (84.9)

454 (86.0)

130 (82.28)

199 (85.78)

101 (88.60)

255 (86.15)

E4*

24 (8.8)

49 (9.3)

16 (10.13)

19 (8.19)

8 (7.02)

30 (10.14)

  1. *No significant difference between patients and controls
  2. # Total patients 136, 79 male and 57 female; and total controls 264, 116 male and 148 female
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us